Related Experiment Video
Updated: Jun 11, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Danthron prevents pulmonary fibrosis through improving mitochondrial function by upregulating carboxylesterase 3
Boyu Li1, Rongman Xu1, Hongyan Zheng1
1Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
Background:
Idiopathic pulmonary fibrosis (IPF) is marked by excessive deposition of extracellular matrix (ECM) and persistent fibroblast activation in the lungs, posing challenges for advancing effective treatment strategies. Danthron, a natural anthraquinone derivative extracted from traditional Chinese medicine rhubarb, exhibits antitumor and antioxidant efficacy.
Methods:
A bleomycin (BLM)-induced pulmonary fibrosis (PF) mouse model and human precision-cut lung slices (hPCLSs) stimulated with a pro-fibrotic solution were employed. The therapeutic effects of danthron on PF were measured by histological manifestations, immunostaining and expression levels of fibrotic markers. Human fibroblasts (HFs) were utilized to explore the underlying mechanism of danthron on fibroblast function.
Results:
Our data showed that danthron significantly mitigated BLM-induced PF by reducing collagen deposition and Ashcroft scores in mice. Danthron also suppressed the abundance of fibrotic markers in mouse lungs and hPCLSs. Additionally, danthron impeded the transition of lung fibroblasts to myofibroblasts while promoting their dedifferentiation. Mechanistically, the anti-fibrotic effect of danthron was associated with the upregulation of carboxylesterase 3 (CES3), which consequently enhanced mitochondrial function and mitophagy in fibroblasts. Pharmacological CES3 inhibition (WWL229) reversed these effects, whereas genetic CES3 overexpression potentiated its mitochondrial benefits. Moreover, WWL229 nullified the beneficial effects of danthron in BLM-induced PF. The downregulation of CES3 was identified in IPF patients, which exhibited a negative correlation with fibrotic genes.
Conclusions:
This study demonstrated danthron as a valuable experimental tool for identifying relevant targets in preclinical models while underscoring CES3 as a potential therapeutic target for PF.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease II: Emphysema